Article
Generation of new cytotoxic human ribonuclease variants directed to the nucleus.
Molecular pharmaceutics - 1 Oct 2012
Vert Anna, Castro Jessica, Ruiz-Martínez Santiago, Tubert Pere, Escribano Diego, Ribó Marc, Vilanova Maria, Benito Antoni
Abstract excerpt
Ribonucleases are promising agents for use in anticancer therapy. Engineering a nuclear localization signal into the sequence of the human pancreatic ribonuclease has been revealed as a new strategy to endow this enzyme with cytotoxic activity against tumor cells. We previously described a cytotoxic human pancreatic ribonuclease variant, named PE5, which is able to cleave nuclear RNA, inducing the apoptosis of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
